The Perils in Managing mRNA Supply Chains. Get it Wrong, People Die—Part 1

This is my patch

When I say ‘this is my patch’, it means I have a 40-year career in building, managing and improving biologics supply chains. That includes the mRNA (and viral vector based) gene-modified cell therapies. I hope, therefore, that subscribers will be inclined to believe what I am about to cover.

I was there

I worked on the drug substance suppl…